Fetal NRBC Immunoselection for Accurate Prenatal Genetic Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating fetal nucleated red blood cells (NRBCs) from maternal blood are inefficient and unreliable, leading to inconsistent detection of fetal genetic abnormalities due to low recovery rates and high false positive/negative rates, which are essential for accurate prenatal diagnosis.
Innovation Solution
A method involving positive selection techniques, such as immunoselection using antibodies like 4B9, combined with negative selection and cell density separation, to enrich and isolate fetal NRBCs from maternal blood samples, followed by diagnostic testing using techniques like STR analysis to confirm fetal cell identity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current isolation methods are used for fetal NRBCs, then the process is simpler, but the recovery rate and accuracy are low
Solution Approach 1:
The isolation process is divided into multiple sequential steps: density gradient separation to concentrate mononuclear cells, followed by positive immunoselection using anti-CD71 antibodies to specifically bind fetal NRBCs, and negative selection to remove contaminating maternal cells. This segmentation allows each step to target specific cell populations, progressively enriching for fetal NRBCs while removing other cell types, thereby achieving high purity and recovery rates through a systematic multi-stage approach
Solution Approach 2:
Immunoselection antibodies (anti-CD71 and anti-HbF) serve as intermediaries that specifically recognize and bind to fetal NRBC surface markers. These antibodies act as mediators between the fetal NRBCs and magnetic beads or fluorescent labels, enabling specific identification and separation of fetal cells from maternal blood without directly manipulating the fetal cells themselves. This intermediary approach ensures high specificity and reduces false positives
2Measurement precision
If invasive procedures like chorionic villus sampling are used, then definitive chromosomal abnormality detection is achieved, but the risk of fetal loss and maternal complications increases
Solution Approach 1:
The method extracts fetal NRBCs from maternal circulation through non-invasive blood sampling. By isolating fetal cells that naturally cross the placental barrier into maternal blood, the technique obtains fetal genetic material without requiring invasive procedures like chorionic villus sampling or amniocentesis. This extraction approach eliminates the mechanical trauma and infection risks associated with invasive techniques while maintaining diagnostic accuracy through direct fetal cell analysis
Solution Approach 2:
The method uses fetal NRBCs as a surrogate copy of fetal tissue for diagnostic analysis. Instead of directly sampling fetal tissue through invasive procedures, the fetal cells circulating in maternal blood serve as representative copies that contain the same chromosomal and genetic information. This copying principle allows definitive diagnostic testing on fetal material without disturbing the fetus or requiring invasive access to fetal compartments
3Object-affected harmful factors
If cell-free DNA testing is used, then non-invasive prenatal testing is achieved, but the ability to detect microdeletions and microinsertions is limited
Solution Approach 1:
The method performs preliminary enrichment and concentration of fetal NRBCs before diagnostic analysis. By pre-concentrating fetal cells using density gradient separation and immunoselection, sufficient quantities of intact fetal cells are obtained for comprehensive genetic testing. This preliminary action ensures that there is enough high-quality fetal cellular material to perform detailed chromosomal analysis, microdeletion detection, and microinsertion identification that would not be possible with limited cell-free DNA
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances the recovery and accuracy of fetal NRBC isolation, allowing for reliable genetic analysis and detection of fetal abnormalities, reducing the need for invasive procedures and improving diagnostic precision.
Implementation Method 1
contacting the biological sample with one or more positive immunoselective antibodies in a fluid medium, wherein the positive immunoselective antibody selectively binds to fNRBCs relative to one or more other cell types in the biological sample
Implementation Method 2
The positive selection can be used in conjunction with negative selection, typically negative immunoselection. Negative immunoselection can comprise the steps of: (a) contacting the biological sample with a negative immunoselective antibody in a fluid medium
Implementation Method 3
A method involving positive selection techniques, such as immunoselection using antibodies like 4B9, combined with negative selection and cell density separation
Data Source
AI summary
The disclosure relates to methods of preparation of fetal nucleated red blood cells (NRBCs) from biological samples for diagnostic testing.